Pomezia, Italy

Sabrina Fiumi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ares Trading S.a.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sabrina Fiumi. Retrieved from https://idiyas.com/inventor/sabrina-fiumi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sabrina Fiumi: Innovator in Glycoprotein Purification

Introduction

Sabrina Fiumi is a notable inventor based in Pomezia Roma, Italy. She has made significant contributions to the field of biochemistry, particularly in the purification of glycoproteins. Her innovative methods have the potential to enhance the efficiency of biopharmaceutical production.

Latest Patents

Sabrina Fiumi holds a patent for a method for purifying FSH or a FSH mutant. The invention relates to a method that involves several steps, including dye affinity chromatography, weak anion exchange chromatography, hydrophobic interaction chromatography, and strong anion exchange chromatography. This method can be executed in any order, providing flexibility in the purification process.

Career Highlights

Fiumi is currently associated with Ares Trading S.a., where she applies her expertise in biochemistry. Her work focuses on developing innovative solutions for the purification of complex proteins, which is crucial for various medical applications.

Collaborations

Some of her notable coworkers include Thierry Ziegler and Mara Rossi. Their collaborative efforts contribute to advancing research and development in the field of glycoprotein purification.

Conclusion

Sabrina Fiumi's contributions to the field of biochemistry, particularly through her patented methods, highlight her role as an innovator in glycoprotein purification. Her work continues to influence advancements in biopharmaceutical production.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…